Laura E. Benjamin

President and Chief Executive Officer at Myris Therapeutics.

Raised on Myris Therapeutics filings

$500K

of $4.5M offered across 1 Form D filing

Company

Biotech · Sharpsburg, PA

High-payload antibody drug conjugates for cancer

High-payload antibody drug conjugates for cancer

Myris Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Oct 14, 2026	Other	$500K/ $4.5M	Form D

Also named on Myris Therapeutics filings